Dr. Ziegelmann on novel injection for patients with Peyronie's disease

"Essentially, we were interested in learning whether there was a change in the amount of curvature with each injection cycle of Xiaflex," says Matthew J. Ziegelmann, MD.

Expert Forum on Bladder Cancer: Nadofaragene Firadenovec for BCG-unresponsive NMIBC

“It is a promising drug in terms of the 3-month complete response rate,” says Chad Ritch, MD, MBA, FACS.

Dr. Koontz gives an overview of ASTRO discussion on new RTOG-0815 data

“I would say what RTOG-0815 has provided is data to have an intelligent conversation with our patients and provide them numbers so that they know what to expect,” says Bridget F. Koontz, MD.